Belimumab (Anti-TNFSF13B / BAFF / CD257)
Belimumab (Anti-TNFSF13B / BAFF / CD257) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab can be used for systemic lupus erythematosus (SLE) research. MW : 144.56 kDa.
| Trivial name | Benlysta, LymphoStat B |
| Catalog Number | A2316 |
| CAS# | 356547-88-1 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/belimumab-anti-tnfsf13b-baff-cd257.html |